Epstein Secrets

m." Ignatius: Ratcliffe Facing "Moment Of Truth." In a column for the Washington Pnst (10/22, 14.2M) entitled, "Can Trump's Spy Chief Be Trusted?," David Ignatius writes that DNI Ratcliffe's performance "has often seemed to emphasize...serving the political interests of the man who appointed him, President Tr

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AE (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

rumps-spy-chief-be-trusted/2020/10/22/60e9e33e-14a1-11eb- ad6f-36c93e6e94fb_story.html> (10/22, 14.2M) entitled, "Can Trump's Spy Chief Be Trusted?," David Ignatius writes that DNI Ratcliffe's performance "has often seemed to emphasize...serving the political interests of the man who appointed him, President Tr

for treatments." Calling the meeting "an usual step," the AP <https://apnews.corn/article/virus-outbreak- e49203f5c55ba593ca587a56d0116b97> (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust a

m." Ignatius: Ratcliffe Facing "Moment Of Truth." In a column for the Washington Post (10/22, 14.2M) entitled, "Can Trump's Spy Chief Be Trusted?," David Ignatius writes that DNI Ratcliffe's performance "has often seemed to emphasize...serving the political interests of the man who appointed him, President Tr

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AP (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust